Search results

75 items
  1. Trends in Drug Law Reform in Europe and Latin America

    • Martin Jelsma
    26 January 2010

    This presentation gives a short overview of legislative reforms in Europe and Latin America that provide lessons learned in practice about less punitive approaches intended to reduce drug-related harm to the individual and society.  Evidence suggests that fears that softening drug laws and their enforcement would lead to sharp increases in drug use, have proven untrue.

     

  2. Image of UN Flag

    Coca chewing out of the UN convention?

    01 March 2010

    This briefing offers some background on the issue to amend the UN Single Convention towards a more coherent and realistic stance on the ancient tradition of coca leaf chewing. The issue was raised by Bolivia and adopted at the July 2009 ECOSOC meeting. Noticing confusion amongst some countries about the motives and impact of such amendment, this briefing aims to shed some light on the case.   

     

  3. Risk assessment of new psychoactive substances

    30 June 2009
    Report

    The principal aim of these guidelines is to put in place a sound methodological and procedural basis for carrying out each risk assessment. The risk assessment has regard to the health and social risks of the use of, manufacture of, and traffic in the new psychoactive substance, the involvement of organised crime and the possible consequences of control measures. The guidelines were finalised and adopted by the EMCDDA’s Scientific Committee in November 2008.

  4. Ranking van drugs

    • J.G.C. van Amsterdam, A. Opperhuizen, M.W.J. Koeter, L.A.G.J.M. van Aerts, W. van den Brink
    30 June 2009
    Report

    In its report Ranking of drugs: A comparison of the harmful effects of drugs, the National Institute for Public Health and the Environment (RIVM) has performed a risk assessment on the harmful effects of 17 drugs plus that of tobacco and alcohol. These 19 items were ranked according to their degree of harm.

  5. Development of a rational scale to assess the harm of drugs of potential misuse

    • David Nutt, Leslie A King, William Saulsbury, Colin Blakemore
    24 March 2007
    Paper

    Drug misuse and abuse are major health problems. Harmful drugs are regulated according to classification systems that purport to relate to the harms and risks of each drug. However, the methodology and processes underlying classification systems are generally neither specified nor transparent, which reduces confidence in their accuracy and undermines health education messages.

  6. The global political economy of scheduling

    • William B. McAllister
    26 February 2004
    Paper

    This article explains the international context of regulation to control addicting substances that gave rise to schedules. It discusses the impact of scheduling decisions on subsequent national drug control legislation and international drug control negotiations, highlighting how the creation of schedules introduced new incentives and rewards into calculations about the national/international commerce in drugs.

  7. Estimating drug harms: a risky business?

    • David Nutt
    01 October 2009

    No one is suggesting that drugs are not harmful. The critical question is one of scale and degree. We need a full and open discussion of the evidence and a mature debate about what the drug laws are for - and whether they doing their job? In `Estimating drug harms: a risky business', Professor David Nutt, of Imperial College London argues that the relative harms of legal drugs such as alcohol and tobacco are greater than those of a number of illegal drugs, including cannabis, LSD and ecstasy.

  8. Guidance on the WHO review of psychoactive substances for international control

    17 December 2009
    Paper

    The 1961 UN Single Convention on Narcotic Drugs and the 1971 Convention on Psychotropic Substances, entrust the Expert Committee on Drug Dependence of the World Health Organization (WHO) with the responsibility of assessing substances for abuse liability in order to make recommendations on their control under the two aforementioned Conventions.

  9. Development of the Convention on Psychotropic Substances, 1971

    01 July 1989
    Paper

    The 196l Single Convention did not include so-called "psychotropic substances" such as amphetamines and barbiturates among the drugs controlled. The discussions on the scope of control were focused on plant-based drugs, such as cannabis, poppy cultivation, poppy straw, coca bush and coca leaves This document describes the development of an international instrument for the control of psychotropic substances.

  10. Cannabis: Classification and Public Health

    01 April 2008
    Report

    The Advisory Council on the Misuse of Drugs reviewed the classification of cannabis in the light of real public concern about the potential mental health effects of cannabis use and, in particular, the use of stronger strains of the drug.

  11. MDMA (‘ecstasy’)

    01 February 2008
    Report

    Due to its prevalence of use, MDMA is a significant public health issue. The Council believes that criminal justice measures will only have limited effect and strongly advises the promulgation of public health messages. It is of vital importance that issues of classification do not detract from messages concerning public health.

  12. Review of the UK’s Drugs Classification System

    • Crime, Drug Strategy Directorate
    01 May 2006

    The UK system of classifying drugs according to their harmfulness has been in place since the introduction of the Misuse of Drugs Act in 1971. Over the past 35 years patterns of drug use have changed quite significantly, and recent debates about the classification of certain drugs, especially cannabis, have led to questions about the clarity of the current system and whether it remains fit for purpose.

     

  13. Drug Law Reform: Lessons from the New Zealand Experience

    • Sanji Gunasekara
    19 August 2010

    In 2007, the Government of New Zealand entrusted an independent agency, the National Law Commission, to review the country’s drug law. The Commission will  present a final report which is likely to feature a new approach to personal pos­session and use of drugs placing less emphasis on conviction and punish­ment and more on the delivery of effective treat­­ment. New Zealand’s approach to drug law reform may provide les­sons for other countries.

     

  14. The current state of drug policy debate

    • Martin Jelsma
    30 April 2008

    Martin Jelsma, from the Transnational Institute, prepared an analysis for the Latin American Commission on Drugs and Democracy, explaining the drug policy situation in the European Union and the current state of debate in the United Nations agenda. The commission is an initiative born of former presidents Fernando Henrique Cardoso, from Brazil, César Gaviria, from Colombia and Ernesto Zedillo, from Mexico, to respond to concerns related to the problems of drug consumption and traffic in Latin America. The idea to constitute a commission capable of consolidating a debate concerning this problematic also responds to the necessity of reviewing the world drug policies in the scope of the United Nations, which began in March 2008.

  15. IDPC Drug Policy Guide

    01 March 2010

    This is the second edition of the IDPC Drug Policy Guide aimed at national government policy makers. This publication is a collaborative effort by a number of members of the International Drug Policy Consortium (IDPC) and partners, and brings together global evidence and best practices on the design and implementation of drug policies and programmes at national level.

     

  16. Coca chewing out of the UN convention?

    01 March 2010

    This briefing offers some background on the issue to amend the UN Single Convention towards a more coherent and realistic stance on the ancient tradition of coca leaf chewing. The issue was raised by Bolivia and adopted at the July 2009 ECOSOC meeting. Noticing confusion amongst some countries about the motives and impact of such amendment, this briefing aims to shed some light on the case.

  17. Drug harms in the UK

    • David J Nutt, Leslie A King, Lawrence D Phillips, on behalf of the Independent Scientific Committee on Drugs
    01 November 2010
    Paper

    To provide better guidance to policy makers in health, policing, and social care, the harms that drugs cause need to be properly assessed. This task is not easy because of the wide range of ways in which drugs can cause harm. This study undertook a review of drug harms with the multicriteria decision analysis (MCDA) approach. This technology has been used successfully to lend support to decision makers facing complex issues characterised by many, conflicting objectives.

  18. The concept of ‘drug harms’

    • Peter Cohen
    28 December 2010
    Paper

    In my view, perceived harms associated with drugs are vulnerable to so many restrictions on reliability and validity that, for the time being, a serious estimate of drug harm per drug is impossible. In my view, it is even invalid to associate harms to drugs alone. Drugs are used by humans, under individual, social and legal conditions, in certain purities and dosages. Whatever the 'effects' of drugs, harmful or not, they cannot be estimated or even discussed without associating the drug with a particular user or user culture. Drugs per se do not meaningfully exist.

  19. Politics and science in classifying the dangers of drugs

    • Robin Room, Dan I. Lubman
    01 November 2010

    There is a long history of psychoactive substances being regarded as dangerous and subsequently being banned or forbidden. Often the bans were introduced on substances new and unfamiliar to a society, which were viewed as more dangerous than substances which were well known and enculturated. With industrialisation and the globalisation brought by European empires, the growing availability of psychoactive substances was increasingly seen as a problem in the 1800s, setting off social and policy reactions – what we know as the temperance movement against alcohol,
    and initial UK legislation limiting the sale of ‘poisons’.

  20. TNI Expert Seminar on the Classification of Controlled Substances

    10 December 2009
    Report

    The classification of drugs has a profound impact on the lives and well-being of individuals across the world and where the classification is incorrect, people suffer unnecessarily. This is an issue that deserves greater public awareness and greater engagement with citizenry and that where such public awareness is in place it should be galvanised in order to work towards a new democratic answer to this difficult situation.

Pages